Rapamycin: From Microbial Discovery to Therapeutic Innovations — Advances, Challenges, and Future Prospects
Journal of Advanced Multidisciplinary Studies (JAMS) · 30.10.2026
DOI: 10.68050/jams.2026.893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Multidisciplinary Studies (JAMS), online erschienen am 30.10.2026. Verfasst von Dr. Sachin T Jose. Die Arbeit nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Rapamycin (sirolimus), originally isolated from Streptomyces hygroscopicus, is a macrolide compound that has profoundly influenced modern biomedical research through its inhibition of the mechanistic target of rapamycin (mTOR) pathway.
Objective
This review aims to synthesize current knowledge on the microbiological origin, molecular mechanisms, therapeutic applications, and biotechnological optimization of rapamycin, with emphasis on recent advances and emerging challenges.
Methods
A comprehensive literature analysis was conducted using peer-reviewed articles focusing on rapamycin biosynthesis, mTOR signaling, clinical applications, and production strategies.
Results
Rapamycin and its analogs (rapalogs) demonstrate significant clinical value in transplantation, oncology, neurodegenerative diseases, and aging research. Advances in metabolic engineering, synthetic biology, and nanodelivery systems have substantially improved production yields and pharmacological performance. However, limitations related to solubility, bioavailability, metabolic side effects, and long-term safety remain.
Conclusion
Rapamycin remains a cornerstone molecule linking microbial natural products to translational medicine. Continued optimization of its production and selective modulation of mTOR signaling are critical for expanding its future therapeutic potential.
Zitieren
APA
Jose, D. S. T. (2026). Rapamycin: From Microbial Discovery to Therapeutic Innovations — Advances, Challenges, and Future Prospects. Journal of Advanced Multidisciplinary Studies (JAMS). https://doi.org/10.68050/jams.2026.893
Vancouver
Jose DST. Rapamycin: From Microbial Discovery to Therapeutic Innovations — Advances, Challenges, and Future Prospects. Journal of Advanced Multidisciplinary Studies (JAMS). 2026. doi:10.68050/jams.2026.893
BibTeX
@article{Jose2026,
author = {Jose, Dr. Sachin T},
title = {Rapamycin: From Microbial Discovery to Therapeutic Innovations — Advances, Challenges, and Future Prospects},
journal = {Journal of Advanced Multidisciplinary Studies (JAMS)},
year = {2026},
doi = {10.68050/jams.2026.893}
}
EUVIMED